The three largest pharmacy benefit managers (PBMs) inflated the price of specialty generic drugs beyond their costs of ...
The Federal Trade Commission accuses CVS, Cigna and UnitedHealth of artificially inflating prices on specialty generic drugs ...
A report published Tuesday shows hundreds and thousands of percent markups on HIV, hypertension and cancer drugs for Medicare ...
The U.S. Federal Trade Commission on Tuesday published the second part of its investigation into how prescription drug ...
Analysts and investors are awaiting details behind UnitedHealth Group's 2025 outlook when it reports quarterly results on ...
Eleven leading policy strategists are scheduled to debate how market changes and the Trump administration will shape 2025, ...
The Federal Trade Commission has published a report that found pharmacy benefit managers Caremark Rx LLC (CVS), Express Scripts and OptumRx marked up numerous specialty generic drugs by ...
T]he sentence was, in the words of the New York Times, ‘rare and lenient.’ But that does not mean Trump has not been punished in the case. The truth is the opposite. Trump paid a serious price in time ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback